These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


250 related items for PubMed ID: 2500900

  • 21. Successful closure of intestinal fistulae in an infant using the somatostatin analogue SMS 201-995.
    Wallace AM, Newman K.
    J Pediatr Surg; 1991 Sep; 26(9):1097-100. PubMed ID: 1941488
    [Abstract] [Full Text] [Related]

  • 22. [Somatostatin and/or total parenteral nutrition for the treatment of intestinal fistulas].
    Planas M, Porta I, Anglés R, Baena JA, Serra J, Padró JB.
    Rev Esp Enferm Dig; 1990 Dec; 78(6):345-7. PubMed ID: 1982616
    [Abstract] [Full Text] [Related]

  • 23. Role of somatostatin analogues in the management of enterocutaneous fistulae.
    Jamil M, Ahmed U, Sobia H.
    J Coll Physicians Surg Pak; 2004 Apr; 14(4):237-40. PubMed ID: 15228830
    [Abstract] [Full Text] [Related]

  • 24. Somatostatin treatment of gastrointestinal fistulae.
    Palnaes Hansen C, Hegnhøj J, Olsen O.
    Ann Chir Gynaecol; 1989 Apr; 78(2):124-6. PubMed ID: 2572196
    [Abstract] [Full Text] [Related]

  • 25. Parenteral and enteral nutrition and the enterocutaneous fistula treatment. II. Factors influencing the outcome of treatment.
    Dárdai E, Pirityi S, Nagy L.
    Acta Chir Hung; 1991 Apr; 32(4):305-18. PubMed ID: 1844622
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. [Effect of a synthetic somatostatin analogue with delayed action (SMS 201-995) on the biliary expenditure in a patient with an external biliary tract fistula].
    Miranda-Ruiz R, Castañón-González J, Pérez Aldana C, Arias E, Díaz de León Ponce M, Zárate A.
    Rev Gastroenterol Mex; 1990 Apr; 55(2):67-9. PubMed ID: 2287871
    [Abstract] [Full Text] [Related]

  • 28. Surgical and nutritional management of postoperative duodenal fistulas.
    Garden OJ, Dykes EH, Carter DC.
    Dig Dis Sci; 1988 Jan; 33(1):30-5. PubMed ID: 3123177
    [Abstract] [Full Text] [Related]

  • 29. Causes and management of postoperative enterocutaneous fistulas.
    Memon AS, Siddiqui FG.
    J Coll Physicians Surg Pak; 2004 Jan; 14(1):25-8. PubMed ID: 14764257
    [Abstract] [Full Text] [Related]

  • 30. Treatment of enterocutaneous and colocutaneous fistulas with early surgery or somatostatin analog.
    Borison DI, Bloom AD, Pritchard TJ.
    Dis Colon Rectum; 1992 Jul; 35(7):635-9. PubMed ID: 1351835
    [Abstract] [Full Text] [Related]

  • 31. Enterocutaneous fistula: are treatments improving?
    Draus JM, Huss SA, Harty NJ, Cheadle WG, Larson GM.
    Surgery; 2006 Oct; 140(4):570-6; discussion 576-8. PubMed ID: 17011904
    [Abstract] [Full Text] [Related]

  • 32. Enterocutaneous fistulas. Effects of total parenteral nutrition and surgery.
    Zera RT, Bubrick MP, Sternquist JC, Hitchcock CR.
    Dis Colon Rectum; 1983 Feb; 26(2):109-12. PubMed ID: 6401615
    [Abstract] [Full Text] [Related]

  • 33. Management of a high-output postoperative enterocutaneous fistula with a vacuum sealing method and continuous enteral nutrition.
    Hyon SH, Martinez-Garbino JA, Benati ML, Lopez-Avellaneda ME, Brozzi NA, Argibay PF.
    ASAIO J; 2000 Feb; 46(4):511-4. PubMed ID: 10926156
    [Abstract] [Full Text] [Related]

  • 34. Nutrition and enterocutaneous fistulas.
    Makhdoom ZA, Komar MJ, Still CD.
    J Clin Gastroenterol; 2000 Oct; 31(3):195-204. PubMed ID: 11033997
    [Abstract] [Full Text] [Related]

  • 35. [Post-nephrectomy duodeno-cutaneous fistula resolved with parenteral nutrition and octreotide (somatostatin analogue)].
    Batista Miranda JE, Solé Balcells FJ, Peñalba F, Mayoral J.
    Arch Esp Urol; 1994 Oct; 47(8):810-2. PubMed ID: 7818305
    [Abstract] [Full Text] [Related]

  • 36. Octreotide and postoperative enterocutaneous fistulae: a controlled prospective study.
    Scott NA, Finnegan S, Irving MH.
    Acta Gastroenterol Belg; 1993 Oct; 56(3-4):266-70. PubMed ID: 8266769
    [Abstract] [Full Text] [Related]

  • 37. Management of digestive fistulas.
    Ysebaert D, Van Hee R, Hubens G, Vaneerdeweg W, Eyskens E.
    Scand J Gastroenterol Suppl; 1994 Oct; 207():42-4. PubMed ID: 7701267
    [Abstract] [Full Text] [Related]

  • 38. Somatostatin versus octreotide in the treatment of patients with gastrointestinal and pancreatic fistulas.
    Leandros E, Antonakis PT, Albanopoulos K, Dervenis C, Konstadoulakis MM.
    Can J Gastroenterol; 2004 May; 18(5):303-6. PubMed ID: 15152279
    [Abstract] [Full Text] [Related]

  • 39. Octreotide for enterocutaneous fistulas of Crohn's disease.
    Lavy A, Yasin K.
    Can J Gastroenterol; 2003 Sep; 17(9):555-8. PubMed ID: 14532930
    [Abstract] [Full Text] [Related]

  • 40. The treatment of high enterocutaneous fistula with surgical drainage and total parenteral nutrition.
    Harju E, Pessi T, Koikkalainen T, Koskinen A.
    Int Surg; 1985 Sep; 70(1):33-8. PubMed ID: 3926685
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 13.